Leerink Partnrs Has Bullish Outlook for Exelixis Q3 Earnings
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Equities researchers at Leerink Partnrs lifted their Q3 2025 EPS estimates for Exelixis in a research note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst A. Berens now forecasts that the biotechnology company will post earnings per share of $0.61 for the quarter, up from their […]
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Equities researchers at Leerink Partnrs lifted their Q3 2025 EPS estimates for Exelixis in a research note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst A. Berens now forecasts that the biotechnology company will post earnings per share of $0.61 for the quarter, up from their […]